Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Laboratory Corporation of America

Laboratory Corporation of America

Sep 16, 2020

LabCorp's Covance Joins Tempus TIME Trial Program

Covance hopes to improve and accelerate oncology clinical trial matching with the Tempus technology platform and network.

Sep 08, 2020

As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza

Premium

Healthcare providers need multiplexed tests that can differentiate the flu from the coronavirus so they can treat patients quickly and appropriately.

Aug 14, 2020

Mission Bio Seeks to Increase Drug Trial Collaborations, Improve Gene and Cell Therapy Efficacy

Premium

Mission Bio will use a recent $70 million funding round to develop quality control assays using its Tapestri single-cell analysis platform.

Jul 25, 2020

FDA Reissues EUA for LabCorp Molecular SARS-CoV-2 Test for Asymptomatic Population, Pooled Testing

The FDA reissued the EUA after analyzing LabCorp data that showed the test could detect SARS-CoV-2 in a general asymptomatic population.

Apr 29, 2020

COVID-19 Testing Could Get Boost From Alternative Sample Types

Premium

Replacing nasopharyngeal swabs with saliva samples or nasal swabs could increase throughput and convenience, as well as relieve reagent and equipment shortages.

Apr 22, 2020

Swab from the Couch

LabCorp has received US Food and Drug Administration authorization for at-home sample collection for its COVID-19 test, 360Dx reports.

Apr 08, 2020

Pacific Biosciences Shares Spike on SARS-CoV-2 Research Initiatives

Among other projects, PacBio is working with LabCorp to sequence a large number of SARS-CoV-2 genomes from de-identified positive samples.

Apr 03, 2020

With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

MicroGen Dx's Texas-based lab is the only commercial laboratory in the US offering sputum testing for SARS-CoV-2.

Mar 20, 2020

COVID-19 Immune Response to be Mapped by Adaptive Biotechnologies, Microsoft

Illumina, LabCorp, and Providence healthcare will join the effort to collect COVID-19 patient samples in the US for immune cell receptor sequencing.

Mar 16, 2020

FDA Grants Emergency Use Authorization for Coronavirus Assays From Hologic, LabCorp

Hologic and LabCorp became the third and fourth commercial test makers to receive EUA designation for  assays to detect the coronavirus that causes COVID-19.

Pages

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.